Global Allicin (CAS 539-86-6) Market Growth 2023-2029

Global Allicin (CAS 539-86-6) Market Growth 2023-2029

Allicin (CAS 539-86-6) is the major biologically active component of garlic. First reported by Cavallito and Bailey in 1944, Allicin (CAS 539-86-6) is the key ingredient responsible for the broad-spectrum of anti-bacterial activity in garlic. They are usually used for dietary supplement.

Currently, there is only one manufacture which can produce stabilized allicin-Allicin International, whose allicin brand is AllisureTM. This company didn’t sell pure allicin directly to customers but allicin contained products like AllicinMAX capsule, AllicinMAX cream, AllicinMAX Gel etc.

In this report, allicin amount and price are after conversion.

LPI (LP Information)' newest research report, the “Allicin (CAS 539-86-6) Industry Forecast” looks at past sales and reviews total world Allicin (CAS 539-86-6) sales in 2022, providing a comprehensive analysis by region and market sector of projected Allicin (CAS 539-86-6) sales for 2023 through 2029. With Allicin (CAS 539-86-6) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allicin (CAS 539-86-6) industry.

This Insight Report provides a comprehensive analysis of the global Allicin (CAS 539-86-6) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Allicin (CAS 539-86-6) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Allicin (CAS 539-86-6) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allicin (CAS 539-86-6) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allicin (CAS 539-86-6).

The global Allicin (CAS 539-86-6) market size is projected to grow from US$ 6 million in 2022 to US$ 7 million in 2029; it is expected to grow at a CAGR of 7 from 2023 to 2029.

At present, the major manufacturer of allicin (CAS 539-86-6) is Allicin International. Allicin International is the world leader and is also only one manufacturer.

This report presents a comprehensive overview, market shares, and growth opportunities of Allicin (CAS 539-86-6) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Allicin Liquid

Allicin Powder

Segmentation by application

Oral Dietary Supplement

External Application

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Allicin International

Key Questions Addressed in this Report

What is the 10-year outlook for the global Allicin (CAS 539-86-6) market?

What factors are driving Allicin (CAS 539-86-6) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Allicin (CAS 539-86-6) market opportunities vary by end market size?

How does Allicin (CAS 539-86-6) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.